{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:09:33Z","timestamp":1791252573495,"version":"4.1.0"},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T00:00:00Z","timestamp":1375747200000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:p>Dopamine dysregulation syndrome shares some core behavioral features with psychostimulant addiction, suggesting that dopamine replacement therapy can acquire psychostimulantlike properties in some patients with Parkinson disease (PD). We here report strong experimental evidence supporting this hypothesis in an \u03b1\u2010synuclein rat model of PD. Although levodopa had no effect in controls, it acquired 2 prominent psychostimulantlike properties in Parkinsonian rats: (1) it produced intense reward on its own and in parallel (2) decreased interest in other nondrug reward. These 2 effects may combine to explain the addictive use of levodopa after loss of midbrain dopamine neurons in some PD patients. Ann Neurol 2013;74:140\u2013144<\/jats:p>","DOI":"10.1002\/ana.23881","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T03:34:02Z","timestamp":1363232042000},"page":"140-144","source":"Crossref","is-referenced-by-count":58,"title":["Levodopa gains psychostimulant\u2010like properties after nigral dopaminergic loss"],"prefix":"10.1002","volume":"74","author":[{"given":"Michel","family":"Engeln","sequence":"first","affiliation":[{"name":"Institute of Neurodegenerative Diseases, UMR 5293, F\u201033000 Bordeaux, France University of Bordeaux Bordeaux France"},{"name":"Institute of Neurodegenerative Diseases, UMR 5293, F\u201033000 Bordeaux, France National Center for Scientific Research Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Fasano","sequence":"additional","affiliation":[{"name":"Institute of Experimental Neurology Division of Neuroscience San Raffaele Research Institute Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge H.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Institute of Neurodegenerative Diseases, UMR 5293, F\u201033000 Bordeaux, France University of Bordeaux Bordeaux France"},{"name":"Institute of Neurodegenerative Diseases, UMR 5293, F\u201033000 Bordeaux, France National Center for Scientific Research Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Cador","sequence":"additional","affiliation":[{"name":"Aquitaine Institute of Cognitive and Integrative Neurosciences University of Bordeaux Bordeaux France"},{"name":"Aquitaine Institute of Cognitive and Integrative Neurosciences National Center for Scientific Research Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Baekelandt","sequence":"additional","affiliation":[{"name":"Laboratory for Neurobiology and Gene Therapy Catholic University Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Bezard","sequence":"additional","affiliation":[{"name":"Institute of Neurodegenerative Diseases, UMR 5293, F\u201033000 Bordeaux, France University of Bordeaux Bordeaux France"},{"name":"Institute of Neurodegenerative Diseases, UMR 5293, F\u201033000 Bordeaux, France National Center for Scientific Research Bordeaux France"},{"name":"Neurology Service Bordeaux University Hospital Center Pessac France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre\u2010Olivier","family":"Fernagut","sequence":"additional","affiliation":[{"name":"Institute of Neurodegenerative Diseases, UMR 5293, F\u201033000 Bordeaux, France University of Bordeaux Bordeaux France"},{"name":"Institute of Neurodegenerative Diseases, UMR 5293, F\u201033000 Bordeaux, France National Center for Scientific Research Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,8,6]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00529-5"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200923020-00005"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.4.423"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70287-X"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995"},{"key":"e_1_2_7_7_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2012.08.005","article-title":"Reinforcing properties of pramipexole in normal and parkinsonian rats","volume":"49","author":"Engeln M","year":"2012","journal-title":"Neurobiol Dis"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.03.014"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009296"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22898"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028370"},{"key":"e_1_2_7_12_1","first-page":"81","article-title":"Behavioral correlates of dopaminergic supersensitivity","volume":"9","author":"Iversen SD","year":"1975","journal-title":"Adv Neurol"},{"key":"e_1_2_7_13_1","first-page":"285","article-title":"Actions of dopaminergic agonists on motor function","volume":"9","author":"Costall B","year":"1975","journal-title":"Adv Neurol"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(80)90166-5"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20822"},{"key":"e_1_2_7_16_1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0022-3565(25)30867-0","article-title":"Effects of dopaminergic agonists and antagonists of feeding in intact and 6\u2010hydroxydopamine\u2010treated rats","volume":"201","author":"Heffner TG","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.09.001"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001507"},{"key":"e_1_2_7_19_1","volume-title":"The rat brain in stereotaxic coordinates","author":"Paxinos G","year":"2009"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1200575109"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2012.02.012"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.23881","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.23881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:32:17Z","timestamp":1745973137000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.23881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1002\/ana.23881"],"URL":"https:\/\/doi.org\/10.1002\/ana.23881","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}